70121-1570 RELEUKO - CanMED: NDC

Product NDC:

70121-1570

Brand Name:

RELEUKO

Generic Name:

Filgrastim

Dosage Form Name:

INJECTION, SOLUTION

Administration Route:

Intravenous

Subcutaneous

Substances:

Name: FILGRASTIM

Strength: 480.0

Unit: ug/.8mL

Packages:

Code: 70121-1570-07

Description: 10 SYRINGE in 1 BOX (70121-1570-7) / .8 mL in 1 SYRINGE

Effective Date: Feb. 25, 2022

Discontinued:

Code: 70121-1570-01

Description: 1 SYRINGE in 1 BOX (70121-1570-1) / .8 mL in 1 SYRINGE

Effective Date: Feb. 25, 2022

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Immunostimulant

Minor Class:

Granulocyte Colony-Stimulating Factor

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox